1. Home
  2. INDP vs XWEL Comparison

INDP vs XWEL Comparison

Compare INDP & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • XWEL
  • Stock Information
  • Founded
  • INDP 2000
  • XWEL 2006
  • Country
  • INDP United States
  • XWEL United States
  • Employees
  • INDP N/A
  • XWEL N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • XWEL Other Consumer Services
  • Sector
  • INDP Health Care
  • XWEL Consumer Discretionary
  • Exchange
  • INDP Nasdaq
  • XWEL Nasdaq
  • Market Cap
  • INDP 6.0M
  • XWEL 6.2M
  • IPO Year
  • INDP N/A
  • XWEL N/A
  • Fundamental
  • Price
  • INDP $3.62
  • XWEL $0.99
  • Analyst Decision
  • INDP Strong Buy
  • XWEL
  • Analyst Count
  • INDP 2
  • XWEL 0
  • Target Price
  • INDP $238.00
  • XWEL N/A
  • AVG Volume (30 Days)
  • INDP 1.4M
  • XWEL 30.2K
  • Earning Date
  • INDP 11-11-2025
  • XWEL 11-13-2025
  • Dividend Yield
  • INDP N/A
  • XWEL N/A
  • EPS Growth
  • INDP N/A
  • XWEL N/A
  • EPS
  • INDP N/A
  • XWEL N/A
  • Revenue
  • INDP N/A
  • XWEL $30,601,000.00
  • Revenue This Year
  • INDP N/A
  • XWEL N/A
  • Revenue Next Year
  • INDP N/A
  • XWEL N/A
  • P/E Ratio
  • INDP N/A
  • XWEL N/A
  • Revenue Growth
  • INDP N/A
  • XWEL N/A
  • 52 Week Low
  • INDP $2.22
  • XWEL $0.70
  • 52 Week High
  • INDP $58.24
  • XWEL $2.00
  • Technical
  • Relative Strength Index (RSI)
  • INDP 45.47
  • XWEL 40.51
  • Support Level
  • INDP $2.86
  • XWEL $0.97
  • Resistance Level
  • INDP $4.50
  • XWEL $1.02
  • Average True Range (ATR)
  • INDP 0.99
  • XWEL 0.07
  • MACD
  • INDP 0.25
  • XWEL -0.01
  • Stochastic Oscillator
  • INDP 19.01
  • XWEL 9.59

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About XWEL XWELL Inc.

XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.

Share on Social Networks: